Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Femoston
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Femoston-conti 1mg/5mg tablets
0604011L0BKADBD
|
Femoston | Estradiol with progestogen | Endocrine System | 31,600 |
|
Femoston 1/10mg tablets
0604011L0BKACAP
|
Femoston | Estradiol with progestogen | Endocrine System | 22,341 |
|
Femoston 2/10mg tablets
0604011L0BKAAAM
|
Femoston | Estradiol with progestogen | Endocrine System | 18,972 |
|
Femoston-conti 0.5mg/2.5mg tablets
0604011L0BKAEBL
|
Femoston | Estradiol with progestogen | Endocrine System | 18,941 |
|
Femoston 2/20mg tablets
0604011L0BKABAN
|
Femoston | Estradiol with progestogen | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.